Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
China
· Delayed Price · Currency is CNY 4.320
+0.030 (0.70%)
At close: Mar 10, 2026
SHE:300194 Revenue
Fuan Pharmaceutical (Group) had revenue of 394.87M CNY in the quarter ending September 30, 2025, a decrease of -29.77%. This brings the company's revenue in the last twelve months to 1.71B, down -35.66% year-over-year. In the year 2024, Fuan Pharmaceutical (Group) had annual revenue of 2.39B, down -9.68%.
Revenue (ttm)
1.71B
Revenue Growth
-35.66%
P/S Ratio
2.98
Revenue / Employee
504.59K
Employees
3,392
Market Cap
5.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.39B | -256.28M | -9.68% |
| Dec 31, 2023 | 2.65B | 226.01M | 9.33% |
| Jan 1, 2023 | 2.42B | -31.40M | -1.28% |
| Jan 1, 2022 | 2.45B | 84.80M | 3.58% |
| Dec 31, 2020 | 2.37B | -412.40M | -14.83% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Hicin Pharmaceutical | 615.39M |
| Luoxin Pharmaceuticals Group Stock | 2.49B |
| Hubei Biocause Heilen Pharmaceutical | 430.77M |
| Zhejiang Yatai Pharmaceutical | 326.64M |
| Beijing Science Sun Pharmaceutical | 402.23M |
| Bide Pharmatech | 1.32B |
| Hunan Fangsheng Pharmaceutical | 1.68B |
| Ningbo Menovo Pharmaceutical | 1.54B |